NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it is implementing a restructuring and cost reduction plan involving the elimination of 50 jobs and the streamlining of manufacturing and administrative processes.

A number of the cost reduction measures will begin immediately, and all are expected to be substantially completed by the end of the quarter, the company said. With these changes and other previous cost reductions, Great Basin expects to reduce its annual cash burn by $10 million to $12 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.